Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to mRNA-1083
Related studies linked through entity extraction aliases.
A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2